Intravenous thrombolytic treatment of acute ischaemic stroke: Customized treatment;Intraveneuze trombolyse: De ideale oplossing voor het herseninfarct?

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 22, 2000, Pages 1025-1028

  Kappelle, L J ^a   Van Der Worp, H B ^a  

^a Afd Neurologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; ONSET AGE; STROKE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; FATAL OUTCOME; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0034720551     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Stam J, Koudstaal PJ, Franke CL, Kappelle LJ, Boiten J. Trombolyse voor het herseninfarct: het einde van het begin. Ned Tijdschr Geneeskd 2000;144:1028-32.
3. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, Von Kummer R, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 1999;53(Suppl 4):S3-S14.
4. Clarke WM, Albers GW. The ATLANTIS rt-PA (Alteplase) acute stroke trial: final results. Atlantis Stroke Study Investigators. Stroke 1999;30:234.
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
6. Hacke W, Kaste M, Fieschi C, Von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
7. Jorgensen HS, Nakayama H, Kammersgaard LP, Raaschou HO, Olsen TS. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model. BMJ 1999;319:288-9.
8. Boiten J, Wilmink JT, Lodder J, Troost J. Trombolyse bij patiënten met een acuut herseninfarct: gunstige cerste ervaringen in Maastricht. Ned Tijdschr Geneeskd 2000;144:1062-9.